- Home
- Publications
- Publication Search
- Publication Details
Title
The role of A20 in the pathogenesis of lymphocytic malignancy
Authors
Keywords
-
Journal
Cancer Cell International
Volume 12, Issue 1, Pages 44
Publisher
Springer Nature
Online
2012-11-08
DOI
10.1186/1475-2867-12-44
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acute myeloid leukemia and transcription factors: role of erythroid Krüppel-like factor (EKLF)
- (2012) Rosa Ayala et al. Cancer Cell International
- Regulation of NF-κB signaling by the A20 deubiquitinase
- (2012) Noula Shembade et al. Cellular & Molecular Immunology
- MicroRNAs miR-125a and miR-125b constitutively activate the NF- B pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)
- (2012) S.-W. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic relationships betweenA20/TNFAIP3, chronic inflammation and autoimmune disease
- (2011) Lars Vereecke et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma
- (2011) L. Giulino et al. BLOOD
- Regulation of Toll-like receptor signaling by NDP52-mediated selective autophagy is normally inactivated by A20
- (2011) Megumi Inomata et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas
- (2011) Q. Yan et al. HAEMATOLOGICA
- Expression and distribution of PPP2R5C gene in leukemia
- (2011) Haitao Zheng et al. Journal of Hematology & Oncology
- Current findings for recurring mutations in acute myeloid leukemia
- (2011) Shinichiro Takahashi Journal of Hematology & Oncology
- High nuclear expression of STAT3 is associated with unfavorable prognosis in diffuse large B-cell lymphoma
- (2011) Wu ZL et al. Journal of Hematology & Oncology
- MicroRNA-125b Potentiates Macrophage Activation
- (2011) Aadel A. Chaudhuri et al. JOURNAL OF IMMUNOLOGY
- Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome
- (2011) F C M Braun et al. LEUKEMIA
- Mutations of CARD11 but not TNFAIP3 may activate the NF-κB pathway in primary CNS lymphoma
- (2010) Manuel Montesinos-Rongen et al. ACTA NEUROPATHOLOGICA
- Cleavage by MALT1 induces cytosolic release of A20
- (2010) Claire Malinverni et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Anti-inflammatory subtilase cytotoxin up-regulates A20 through the unfolded protein response
- (2010) Shotaro Nakajima et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Expression, biological activities and mechanisms of action of A20 (TNFAIP3)
- (2010) Lynn Verstrepen et al. BIOCHEMICAL PHARMACOLOGY
- B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice
- (2010) Y. Chu et al. BLOOD
- A20 inhibition of NFκB and inflammation: Targeting E2:E3 ubiquitin enzyme complexes
- (2010) Noula Shembade et al. CELL CYCLE
- Mutation analysis of the TNFAIP3 (A20) tumor suppressor gene in CLL
- (2010) Claudia Philipp et al. INTERNATIONAL JOURNAL OF CANCER
- Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus
- (2010) Lukas P. Frenzel et al. INTERNATIONAL JOURNAL OF CANCER
- Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia
- (2010) Xin Huang et al. Journal of Hematology & Oncology
- Ubiquitin Binding to A20 ZnF4 Is Required for Modulation of NF-κB Signaling
- (2010) Ivan Bosanac et al. MOLECULAR CELL
- MicroRNA miR-125b causes leukemia
- (2010) M. Bousquet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets
- (2010) A. G. L. Ooi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output
- (2010) R. M. O'Connell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA miR-125a controls hematopoietic stem cell number
- (2010) S. Guo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The NF- B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
- (2009) U. Novak et al. BLOOD
- TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
- (2009) K. Honma et al. BLOOD
- Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains
- (2009) David Komander et al. EMBO REPORTS
- TNFAIP3(A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
- (2009) Roland Schmitz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A20 Negatively Regulates T Cell Receptor Signaling to NF- B by Cleaving Malt1 Ubiquitin Chains
- (2009) M. Duwel et al. JOURNAL OF IMMUNOLOGY
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
- (2009) Mara Compagno et al. NATURE
- Frequent inactivation of A20 in B-cell lymphomas
- (2009) Motohiro Kato et al. NATURE
- The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology
- (2009) Lars Vereecke et al. TRENDS IN IMMUNOLOGY
- The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20
- (2008) Noula Shembade et al. NATURE IMMUNOLOGY
- T cell antigen receptor stimulation induces MALT1 paracaspase–mediated cleavage of the NF-κB inhibitor A20
- (2008) Beatrice Coornaert et al. NATURE IMMUNOLOGY
- A20 is an antigen presentation attenuator and its inhibition overcomes regulatory T cell–mediated suppression
- (2008) Xiao-Tong Song et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started